| Metformin use in hidradenitis suppurativa L Jennings, R Hambly, R Hughes, B Moriarty, B Kirby Journal of Dermatological Treatment 31 (3), 261-263, 2020 | 68 | 2020 |
| Naturally derived Heme-Oxygenase 1 inducers attenuate inflammatory responses in human dendritic cells and T cells: Relevance for psoriasis treatment NK Campbell, HK Fitzgerald, A Malara, R Hambly, CM Sweeney, B Kirby, ... Scientific reports 8 (1), 10287, 2018 | 52 | 2018 |
| The relevance of serum vitamin D in psoriasis: a review R Hambly, B Kirby Archives of dermatological research 309, 499-517, 2017 | 51 | 2017 |
| Methadone-maintained patients in primary care have higher rates of chronic disease and multimorbidity, and use health services more intensively than matched controls J O’Toole, R Hambly, AM Cox, B O’Shea, C Darker The European journal of general practice 20 (4), 275-280, 2014 | 45 | 2014 |
| Metformin has anti-inflammatory effects and induces immunometabolic reprogramming via multiple mechanisms in hidradenitis suppurativa A Petrasca, R Hambly, N Kearney, CM Smith, EK Pender, J Mac Mahon, ... British Journal of Dermatology 189 (6), 730-740, 2023 | 23 | 2023 |
| Factors predicting pain and effect of oral analgesia in topical photodynamic therapy. RA Hambly, N Mansoor, C Quinlan, Z Shah, P Lenane, N Ralph, ... Photodermatology, Photoimmunology & Photomedicine 33 (3), 2017 | 17 | 2017 |
| Metformin treatment of hidradenitis suppurativa: effect on metabolic parameters, inflammation, cardiovascular risk biomarkers, and immune mediators R Hambly, N Kearney, R Hughes, JM Fletcher, B Kirby International Journal of Molecular Sciences 24 (8), 6969, 2023 | 15 | 2023 |
| Targeting the NLRP3 inflammasome reduces inflammation in hidradenitis suppurativa skin B Moran, CM Smith, A Zaborowski, M Ryan, J Karman, RW Dunstan, ... British Journal of Dermatology 189 (4), 447-458, 2023 | 14 | 2023 |
| Medication adherence among patients with psoriasis on traditional systemic and biologics treatment R Hambly, A Kelly, E Gilhooley, E Nic Dhonncha, A Murad, R Hughes, ... British Journal of Dermatology 178 (1), e46-e48, 2018 | 10 | 2018 |
| Association of biologic treatment in hidradenitis suppurativa with reduced neutrophil-lymphocyte ratio and platelet-lymphocyte ratio N Kearney, C McCourt, R Hambly, R Hughes, D O’Kane, B Kirby JAMA dermatology 159 (2), 222-224, 2023 | 8 | 2023 |
| Sitagliptin and narrow-band Ultraviolet-B for moderate psoriasis (DINUP): a randomised controlled clinical trial M Lynch, A Malara, I Timoney, S Vencken, T Ahern, F Awdeh, C Sweeney, ... Dermatology 238 (1), 140-147, 2022 | 8 | 2022 |
| Prolonged clindamycin and rifampicin for hidradenitis suppurativa: resist to prevent resistance R Hambly, B Kirby British Journal of Dermatology 180, 701-714, 2019 | 8 | 2019 |
| Topical photodynamic therapy for primary Bowen disease and basal cell carcinoma: optimizing patient selection R Hambly, N Mansoor, C Quinlan, Z Shah, P Lenane, N Ralph, ... British Journal of Dermatology 177 (3), e55-e57, 2017 | 7 | 2017 |
| Innate lymphoid cell (ILC) subsets are enriched in the skin of patients with hidradenitis suppurativa A Petrasca, R Hambly, O Molloy, S Kearns, B Moran, CM Smith, ... Plos one 18 (2), e0281688, 2023 | 6 | 2023 |
| High levels of psychological distress, sleep disturbance, and alcohol use disorder in adults with atopic dermatitis E Gilhooley, C O'Grady, D Roche, JM Mahon, R Hambly, A Kelly, ... Dermatitis 32 (1S1), S33-S38, 2021 | 6 | 2021 |
| B-cell-derived transforming growth factor-β may drive the activation of inflammatory macrophages and contribute to scarring in hidradenitis suppurativa CM Smith, R Hambly, S Gatault, LF Iglesias-Martinez, S Kearns, H Rea, ... British Journal of Dermatology 188 (2), 290-310, 2023 | 5 | 2023 |
| B-cell and complement signature in severe hidradenitis suppurativa that does not respond to adalimumab R Hambly, S Gatault, CM Smith, LF Iglesias-Martinez, S Kearns, H Rea, ... British Journal of Dermatology 188 (1), 52-63, 2023 | 5 | 2023 |
| Biologic survival in hidradenitis suppurativa: much done, more to do R Hambly, B Kirby Br J Dermatol 185 (1), 16-17, 2021 | 4 | 2021 |
| Hydroxychloroquine toxicity and aromatase inhibitors R Hambly, A Lally British Journal of Dermatology 177 (3), 882-882, 2017 | 4 | 2017 |
| ‘Not relevant’responses in the era of COVID‐19: are we underestimating Dermatology Life Quality Index values? N Kearney, R Hambly, A Alsharqi, B Kirby British Journal of Dermatology 186 (1), 187-189, 2022 | 3 | 2022 |
Catherine DarkerTrinity College Dublin, Ireland在 tcd.ie 的电子邮件经过验证
